Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
Reporting on key macro data at the time of release.
Real-time insight on key fixed income and fx markets.
- Emerging MarketsEmerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
- Political RiskPolitical Risk
Intelligence on key political and geopolitical events around the world.
- About Us
One US earnings release that could garner some interest today could be Johnson & Johnson - they're due pre-market. Outside of their EPS and revenue headlines, markets will be looking for any efficacy results of their COVID-19 vaccine, and whether testing is showing an efficacy of 80% or more.
- Bloomberg today citing an Evercore ISI survey, in which their results show investors expect a "sustained rotation into reopening stocks" if the JNJ results show a decent level of effectiveness.
- The last two quarters, JNJ have reported at 1140GMT/0640ET, so that seems a good guide for timing of any release we may see from them today.